{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T02:52:52Z","timestamp":1771469572473,"version":"3.50.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,6,8]],"date-time":"2016-06-08T00:00:00Z","timestamp":1465344000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004522","name":"Top Institute Pharma","doi-asserted-by":"publisher","award":["D4-603"],"award-info":[{"award-number":["D4-603"]}],"id":[{"id":"10.13039\/501100004522","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["612360"],"award-info":[{"award-number":["612360"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["625798"],"award-info":[{"award-number":["625798"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020","doi-asserted-by":"crossref","award":["644373"],"award-info":[{"award-number":["644373"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s11307-016-0972-7","type":"journal-article","created":{"date-parts":[[2016,6,8]],"date-time":"2016-06-08T14:27:53Z","timestamp":1465396073000},"page":"905-915","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pre-clinical Evaluation of a Cyanine-Based SPECT Probe for Multimodal Tumor Necrosis Imaging"],"prefix":"10.1007","volume":"18","author":[{"given":"Marieke A.","family":"Stammes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicky T.","family":"Knol-Blankevoort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis J.","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans R. I. J.","family":"Feitsma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Mezzanotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Cordfunke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Sinisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena A.","family":"Dubikovskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azusa","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph S.","family":"DaCosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Bierau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric L.","family":"Kaijzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J. A.","family":"Snoeks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ermond R.","family":"van Beek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens W. G. M.","family":"L\u00f6wik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,8]]},"reference":[{"key":"972_CR1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ctrv.2008.07.001","volume":"34","author":"EC Bruin de","year":"2008","unstructured":"de Bruin EC, Medema JP (2008) Apoptosis and non-apoptotic deaths in cancer development and treatment response. Cancer Treat Rev 34:737\u2013749","journal-title":"Cancer Treat Rev"},{"key":"972_CR2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/pbc.24038","volume":"59","author":"R Venkatramani","year":"2012","unstructured":"Venkatramani R, Wang L, Malvar J et al (2012) Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma. Pediatr Blood Cancer 59:493\u2013498","journal-title":"Pediatr Blood Cancer"},{"key":"972_CR3","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/sj.bjc.6605854","volume":"103","author":"N Hiraoka","year":"2010","unstructured":"Hiraoka N, Ino Y, Sekine S et al (2010) Tumour necrosis is a postoperative prognostic marker for pancreatic cancer patients with a high interobserver reproducibility in histological evaluation. Br J Cancer 103:1057\u20131065","journal-title":"Br J Cancer"},{"key":"972_CR4","first-page":"1105","volume":"22","author":"T Kato","year":"2002","unstructured":"Kato T, Kameoka S, Kimura T et al (2002) p53, mitosis, apoptosis and necrosis as prognostic indicators of long-term survival in breast cancer. Anticancer Res 22:1105\u20131112","journal-title":"Anticancer Res"},{"key":"972_CR5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10549-009-0360-y","volume":"121","author":"E Maiorano","year":"2010","unstructured":"Maiorano E, Regan MM, Viale G et al (2010) Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy. Breast Cancer Res Treat 121:211\u2013218","journal-title":"Breast Cancer Res Treat"},{"key":"972_CR6","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.athoracsur.2010.12.028","volume":"91","author":"SY Park","year":"2011","unstructured":"Park SY, Lee HS, Jang HJ et al (2011) Tumor necrosis as a prognostic factor for stage IA non-small cell lung cancer. Ann Thorac Surg 91:1668\u20131673","journal-title":"Ann Thorac Surg"},{"key":"972_CR7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1309\/AJCPLBK9L9KDYQZP","volume":"137","author":"M Pichler","year":"2012","unstructured":"Pichler M, Hutterer GC, Chromecki TF et al (2012) Histologic tumor necrosis is an independent prognostic indicator for clear cell and papillary renal cell carcinoma. Am J Clin Pathol 137:283\u2013289","journal-title":"Am J Clin Pathol"},{"key":"972_CR8","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.humpath.2010.04.018","volume":"41","author":"MJ Pollheimer","year":"2010","unstructured":"Pollheimer MJ, Kornprat P, Lindtner RA et al (2010) Tumor necrosis is a new promising prognostic factor in colorectal cancer. Hum Pathol 41:1749\u20131757","journal-title":"Hum Pathol"},{"key":"972_CR9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/bjs.7755","volume":"99","author":"CH Richards","year":"2012","unstructured":"Richards CH, Roxburgh CS, Anderson JH et al (2012) Prognostic value of tumour necrosis and host inflammatory responses in colorectal cancer. Br J Surg 99:287\u2013294","journal-title":"Br J Surg"},{"key":"972_CR10","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1007\/s00247-006-0324-x","volume":"36","author":"M Uhl","year":"2006","unstructured":"Uhl M, Saueressig U, Koehler G et al (2006) Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas. Pediatr Radiol 36:1306\u20131311","journal-title":"Pediatr Radiol"},{"key":"972_CR11","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1016\/j.febslet.2010.10.046","volume":"584","author":"MT Silva","year":"2010","unstructured":"Silva MT (2010) Secondary necrosis: the natural outcome of the complete apoptotic program. FEBS Lett 584:4491\u20134499","journal-title":"FEBS Lett"},{"key":"972_CR12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrd3373","volume":"10","author":"O Kepp","year":"2011","unstructured":"Kepp O, Galluzzi L, Lipinski M et al (2011) Cell death assays for drug discovery. Nat Rev Drug Discov 10:221\u2013237","journal-title":"Nat Rev Drug Discov"},{"key":"972_CR13","first-page":"5842","volume":"48","author":"AL Epstein","year":"1988","unstructured":"Epstein AL, Chen FM, Taylor CR (1988) A novel method for the detection of necrotic lesions in human cancers. Cancer Res 48:5842\u20135848","journal-title":"Cancer Res"},{"key":"972_CR14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5662\/wjm.v3.i4.45","volume":"3","author":"MM Cona","year":"2013","unstructured":"Cona MM, de Witte P, Verbruggen A, Ni Y (2013) An overview of translational (radio)pharmaceutical research related to certain oncological and non-oncological applications. World J Methodol 3:45\u201364","journal-title":"World J Methodol"},{"key":"972_CR15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.7150\/thno.6650","volume":"3","author":"B Jiang","year":"2013","unstructured":"Jiang B, Wang J, Ni Y, Chen F (2013) Necrosis avidity: a newly discovered feature of hypericin and its preclinical applications in necrosis imaging. Theranostics 3:667\u2013676","journal-title":"Theranostics"},{"key":"972_CR16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/bip.10110","volume":"67","author":"J Hritz","year":"2002","unstructured":"Hritz J, Kascakova S, Ulicny J, Miskovsky P (2002) Influence of structure of human, rat, and bovine serum albumins on binding properties of photoactive drug hypericin. Biopolymers 67:251\u2013254","journal-title":"Biopolymers"},{"key":"972_CR17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1389450023348091","volume":"3","author":"P Miskovsky","year":"2002","unstructured":"Miskovsky P (2002) Hypericin\u2014a new antiviral and antitumor photosensitizer: mechanism of action and interaction with biological macromolecules. Curr Drug Targets 3:55\u201384","journal-title":"Curr Drug Targets"},{"key":"972_CR18","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1055\/s-2002-32902","volume":"68","author":"P Solar","year":"2002","unstructured":"Solar P, Cavarga I, Hofmanova J et al (2002) Effect of acetazolamide on hypericin photocytotoxicity. Planta Med 68:658\u2013660","journal-title":"Planta Med"},{"key":"972_CR19","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00262-007-0406-0","volume":"57","author":"H Wang","year":"2008","unstructured":"Wang H, Cao C, Li B et al (2008) Immunogenicity of iodine 131 chimeric tumor necrosis therapy monoclonal antibody in advanced lung cancer patients. Cancer Immunol Immunother 57:677\u2013684","journal-title":"Cancer Immunol. Immunother"},{"key":"972_CR20","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/01.rli.0000171811.48991.5a","volume":"40","author":"Y Ni","year":"2005","unstructured":"Ni Y, Bormans G, Chen F et al (2005) Necrosis avid contrast agents: functional similarity versus structural diversity. Investig Radiol 40:526\u2013535","journal-title":"Investig Radiol"},{"key":"972_CR21","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2217\/fon.12.58","volume":"8","author":"A Hdeib","year":"2012","unstructured":"Hdeib A, Sloan A (2012) Targeted radioimmunotherapy: the role of (1)(3)(1)I-chTNT-1\/B mAb (Cotara) for treatment of high-grade gliomas. Future Oncol 8:659\u2013669","journal-title":"Future Oncol"},{"key":"972_CR22","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s11095-013-1159-4","volume":"31","author":"MM Cona","year":"2014","unstructured":"Cona MM, Alpizar YA, Li J et al (2014) Radioiodinated hypericin: its biodistribution, necrosis avidity and therapeutic efficacy are influenced by formulation. Pharm Res 31:278\u2013290","journal-title":"Pharm Res"},{"key":"972_CR23","doi-asserted-by":"crossref","unstructured":"Xie B, Stammes MA, van Driel PB et al (2015) Necrosis avid near infrared fluorescent cyanines for imaging cell death and their use to monitor therapeutic efficacy in mouse tumor models. Oncotarget","DOI":"10.18632\/oncotarget.5498"},{"key":"972_CR24","doi-asserted-by":"crossref","first-page":"14260","DOI":"10.18632\/oncotarget.3680","volume":"6","author":"MC Boonstra","year":"2015","unstructured":"Boonstra MC, van Driel PB, van Willigen DM et al (2015) uPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgery. Oncotarget 6:14260\u201314273","journal-title":"Oncotarget"},{"key":"972_CR25","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.imbio.2015.07.010","volume":"220","author":"H He","year":"2015","unstructured":"He H, Tu X, Zhang J et al (2015) A novel antibody targeting CD24 and hepatocellular carcinoma in vivo by near-infrared fluorescence imaging. Immunobiology 220:1328\u20131336","journal-title":"Immunobiology"},{"issue":"Suppl 4","key":"972_CR26","doi-asserted-by":"crossref","first-page":"S528","DOI":"10.1245\/s10434-014-3524-x","volume":"21","author":"FP Verbeek","year":"2014","unstructured":"Verbeek FP, van der Vorst JR, Tummers QR et al (2014) Near-infrared fluorescence imaging of both colorectal cancer and ureters using a low-dose integrin targeted probe. Ann Surg Oncol 21(Suppl 4):S528\u2013S537","journal-title":"Ann Surg Oncol"},{"key":"972_CR27","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s10555-014-9505-5","volume":"33","author":"JM Warram","year":"2014","unstructured":"Warram JM, de Boer E, Sorace AG et al (2014) Antibody-based imaging strategies for cancer. Cancer Metastasis Rev 33:809\u2013822","journal-title":"Cancer Metastasis Rev"},{"key":"972_CR28","doi-asserted-by":"crossref","unstructured":"Sato K, Gorka AP, Nagaya T et al (2015) Role of fluorophore charge on the in vivo optical imaging properties of near-infrared cyanine dye\/monoclonal antibody conjugates. Bioconjug Chem","DOI":"10.1021\/acs.bioconjchem.5b00492"},{"key":"972_CR29","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1021\/bi2000966","volume":"50","author":"MY Berezin","year":"2011","unstructured":"Berezin MY, Guo K, Akers W et al (2011) Rational approach to select small peptide molecular probes labeled with fluorescent cyanine dyes for in vivo optical imaging. Biochemistry 50:2691\u20132700","journal-title":"Biochemistry"},{"key":"972_CR30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1152\/physrev.00013.2006","volume":"87","author":"G Kroemer","year":"2007","unstructured":"Kroemer G, Galluzzi L, Brenner C (2007) Mitochondrial membrane permeabilization in cell death. Physiol Rev 87:99\u2013163","journal-title":"Physiol Rev"},{"key":"972_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-4827(02)00027-7","volume":"283","author":"SY Proskuryakov","year":"2003","unstructured":"Proskuryakov SY, Konoplyannikov AG, Gabai VL (2003) Necrosis: a specific form of programmed cell death? Exp Cell Res 283:1\u201316","journal-title":"Exp Cell Res"},{"key":"972_CR32","first-page":"3","volume":"146","author":"G Majno","year":"1995","unstructured":"Majno G, Joris I (1995) Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146:3\u201315","journal-title":"Am J Pathol"},{"key":"972_CR33","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1158\/1078-0432.CCR-12-3598","volume":"19","author":"S Keereweer","year":"2013","unstructured":"Keereweer S, Van Driel PB, Snoeks TJ et al (2013) Optical image-guided cancer surgery: challenges and limitations. Clin Cancer Res 19:3745\u20133754","journal-title":"Clin Cancer Res"},{"key":"972_CR34","first-page":"51776","volume":"JoVE","author":"R Pleijhuis","year":"2014","unstructured":"Pleijhuis R, Timmermans A, De Jong J et al (2014) Tissue-simulating phantoms for assessing potential near-infrared fluorescence imaging applications in breast cancer surgery. J Vis Exp JoVE:51776","journal-title":"J Vis Exp"},{"key":"972_CR35","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13550-015-0120-4","volume":"5","author":"A Paulus","year":"2015","unstructured":"Paulus A, Desai P, Carney B et al (2015) Development of a clickable bimodal fluorescent\/PET probe for in vivo imaging. EJNMMI Res 5:120","journal-title":"EJNMMI Res"},{"key":"972_CR36","doi-asserted-by":"crossref","first-page":"153741","DOI":"10.1155\/2014\/153741","volume":"2014","author":"U Seibold","year":"2014","unstructured":"Seibold U, Wangler B, Schirrmacher R, Wangler C (2014) Bimodal imaging probes for combined PET and OI: recent developments and future directions for hybrid agent development. BioMed Res Int 2014:153741","journal-title":"BioMed Res Int"},{"key":"972_CR37","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1021\/bc500336a","volume":"25","author":"M Morais","year":"2014","unstructured":"Morais M, Campello MP, Xavier C et al (2014) Radiolabeled mannosylated dextran derivatives bearing an NIR-fluorophore for sentinel lymph node imaging. Bioconjug Chem 25:1963\u20131970","journal-title":"Bioconjug Chem"},{"key":"972_CR38","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.3390\/molecules18066425","volume":"18","author":"H Zhu","year":"2013","unstructured":"Zhu H, Zhao J, Lin X et al (2013) Design, synthesis and evaluation of dual-modality glyco-nanoparticles for tumor imaging. Molecules 18:6425\u20136438","journal-title":"Molecules"},{"key":"972_CR39","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1021\/bm4001662","volume":"14","author":"D Majonis","year":"2013","unstructured":"Majonis D, Ornatsky O, Weinrich D, Winnik MA (2013) Dual-purpose polymer labels for fluorescent and mass cytometric affinity bioassays. Biomacromolecules 14:1503\u20131513","journal-title":"Biomacromolecules"},{"key":"972_CR40","doi-asserted-by":"crossref","first-page":"e473","DOI":"10.1038\/cddis.2012.207","volume":"4","author":"BW Xie","year":"2013","unstructured":"Xie BW, Park D, Van Beek ER et al (2013) Optical imaging of cell death in traumatic brain injury using a heat shock protein-90 alkylator. Cell Death Dis 4:e473","journal-title":"Cell Death Dis"},{"key":"972_CR41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2191-219X-2-4","volume":"2","author":"M Brom","year":"2012","unstructured":"Brom M, Joosten L, Oyen WJ et al (2012) Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with 111In in HEPES and MES buffer. EJNMMI Res 2:4","journal-title":"EJNMMI Res"},{"key":"972_CR42","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1088\/0031-9155\/55\/5\/001","volume":"55","author":"MC Goorden","year":"2010","unstructured":"Goorden MC, Beekman FJ (2010) High-resolution tomography of positron emitters with clustered pinhole SPECT. Phys Med Biol 55:1265\u20131277","journal-title":"Phys Med Biol"},{"key":"972_CR43","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1088\/0031-9155\/55\/7\/015","volume":"55","author":"W Branderhorst","year":"2010","unstructured":"Branderhorst W, Vastenhouw B, Beekman FJ (2010) Pixel-based subsets for rapid multi-pinhole SPECT reconstruction. Phys Med Biol 55:2023\u20132034","journal-title":"Phys Med Biol"},{"key":"972_CR44","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s002800050648","volume":"40","author":"GD Paine-Murrieta","year":"1997","unstructured":"Paine-Murrieta GD, Taylor CW, Curtis RA et al (1997) Human tumor models in the severe combined immune deficient (scid) mouse. Cancer Chemother Pharmacol 40:209\u2013214","journal-title":"Cancer Chemother Pharmacol"},{"key":"972_CR45","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.bmcl.2010.10.102","volume":"21","author":"K Prinsen","year":"2011","unstructured":"Prinsen K, Jin L, Vunckx K et al (2011) Radiolabeling and preliminary biological evaluation of a (99m)Tc(CO)(3) labeled 3,3\u2032-(benzylidene)-bis-(1H-indole-2-carbohydrazide) derivative as a potential SPECT tracer for in vivo visualization of necrosis. Bioorg Med Chem Lett 21:502\u2013505","journal-title":"Bioorg Med Chem Lett"},{"key":"972_CR46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1476-5810.2006.00086.x","volume":"4","author":"DM Walleghen Van","year":"2006","unstructured":"Van Walleghen DM, Parseghian MH (2006) Toxicity and biodistribution of an iodine-131-radiolabelled tumour necrosis-targeting antibody in non-tumour-bearing domestic felines. Vet Comp Oncol 4:9\u201320","journal-title":"Vet Comp Oncol"},{"key":"972_CR47","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/neuonc\/nos307","volume":"15","author":"N Verma","year":"2013","unstructured":"Verma N, Cowperthwaite MC, Burnett MG, Markey MK (2013) Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies. Neuro-Oncology 15:515\u2013534","journal-title":"Neuro-Oncology"},{"key":"972_CR48","doi-asserted-by":"crossref","first-page":"W464","DOI":"10.2214\/AJR.13.12222","volume":"203","author":"KP Murphy","year":"2014","unstructured":"Murphy KP, O\u2019Connor OJ, Maher MM (2014) Updated imaging nomenclature for acute pancreatitis. AJR Am J Roentgenol 203:W464\u2013W469","journal-title":"AJR Am J Roentgenol"},{"key":"972_CR49","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jelectrocard.2008.06.010","volume":"41","author":"M Carlsson","year":"2008","unstructured":"Carlsson M, Arheden H, Higgins CB, Saeed M (2008) Magnetic resonance imaging as a potential gold standard for infarct quantification. J Electrocardiol 41:614\u2013620","journal-title":"J Electrocardiol"},{"key":"972_CR50","unstructured":"Pharmaceuticals P Cotara Oncology. (Accessed Oct 26)."},{"key":"972_CR51","doi-asserted-by":"crossref","unstructured":"Ni Y (2014) Abstract 1767: Oncocidia: a small molecule dual targeting pan-anticancer theragnostic strategy. In Proceedings of the 105th Annual Meeting of the American Association for Cancer Research. San Diego, CA. Philadelphia (PA), p 1767.","DOI":"10.1158\/1538-7445.AM2014-1767"},{"key":"972_CR52","doi-asserted-by":"crossref","first-page":"852","DOI":"10.2174\/18715206113136660360","volume":"14","author":"MM Cona","year":"2014","unstructured":"Cona MM, Li J, Feng Y et al (2014) Targetability and biodistribution of radioiodinated hypericin: comparison between microdosing and carrier-added preparations. Anti Cancer Agents Med Chem 14:852\u2013861","journal-title":"Anti Cancer Agents Med Chem"},{"key":"972_CR53","doi-asserted-by":"crossref","first-page":"86006","DOI":"10.1117\/1.JBO.20.8.086006","volume":"20","author":"R Krabbendam","year":"2015","unstructured":"Krabbendam R, Pool M, de Vries LG et al (2015) Hybrid imaging of fluorescently labeled cancer drugs and label-free four-wave mixing microscopy of cancer cells and tissues. J Biomed Opt 20:86006","journal-title":"J Biomed Opt"},{"key":"972_CR54","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2310\/7290.2015.00015","volume":"14","author":"M Rijpkema","year":"2015","unstructured":"Rijpkema M, Bos DL, Cornelissen AS et al (2015) Optimization of dual-labeled antibodies for targeted intraoperative imaging of tumors. Mol Imaging 14:348\u2013355","journal-title":"Mol Imaging"},{"key":"972_CR55","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/nprot.2006.175","volume":"1","author":"JK Sosabowski","year":"2006","unstructured":"Sosabowski JK, Mather SJ (2006) Conjugation of DOTA-like chelating agents to peptides and radiolabeling with trivalent metallic isotopes. Nat Protoc 1:972\u2013976","journal-title":"Nat Protoc"},{"key":"972_CR56","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nprot.2006.49","volume":"1","author":"MS Cooper","year":"2006","unstructured":"Cooper MS, Sabbah E, Mather SJ (2006) Conjugation of chelating agents to proteins and radiolabeling with trivalent metallic isotopes. Nat Protoc 1:314\u2013317","journal-title":"Nat Protoc"},{"key":"972_CR57","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/hep.1840140644","volume":"14","author":"PC Adams","year":"1991","unstructured":"Adams PC, Lin E, Barber KR, Grant CW (1991) Enhanced biliary iron excretion with amphiphilic diethylenetriaminepentaacetic acid. Hepatology 14:1230\u20131234","journal-title":"Hepatology"},{"key":"972_CR58","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s11095-007-9516-9","volume":"25","author":"A Hawe","year":"2008","unstructured":"Hawe A, Sutter M, Jiskoot W (2008) Extrinsic fluorescent dyes as tools for protein characterization. Pharm Res 25:1487\u20131499","journal-title":"Pharm Res"},{"key":"972_CR59","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1200\/JCO.2007.14.3065","volume":"26","author":"JV Frangioni","year":"2008","unstructured":"Frangioni JV (2008) New technologies for human cancer imaging. J Clin Oncol 26:4012\u20134021","journal-title":"J Clin Oncol"},{"key":"972_CR60","unstructured":"ATCC (2012) SOP: Thawing, propagating and cryopreserving of NCI-PBCF-HTB22 (MCF-7)."},{"key":"972_CR61","doi-asserted-by":"crossref","first-page":"e9364","DOI":"10.1371\/journal.pone.0009364","volume":"5","author":"JB Kim","year":"2010","unstructured":"Kim JB, Urban K, Cochran E et al (2010) Non-invasive detection of a small number of bioluminescent cancer cells in vivo. PLoS One 5:e9364","journal-title":"PLoS One"},{"key":"972_CR62","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.4049\/jimmunol.166.6.4195","volume":"166","author":"GC Koo","year":"2001","unstructured":"Koo GC, Huang C, Camacho R et al (2001) Immune enhancing effect of a growth hormone secretagogue. J Immunol 166:4195\u20134201","journal-title":"J Immunol"},{"key":"972_CR63","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2","volume":"65","author":"S Friberg","year":"1997","unstructured":"Friberg S, Mattson S (1997) On the growth rates of human malignant tumors: implications for medical decision making. J Surg Oncol 65:284\u2013297","journal-title":"J Surg Oncol"},{"key":"972_CR64","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11010-012-1250-x","volume":"365","author":"MU Rehman","year":"2012","unstructured":"Rehman MU, Tahir M, Ali F et al (2012) Cyclophosphamide-induced nephrotoxicity, genotoxicity, and damage in kidney genomic DNA of Swiss albino mice: the protective effect of Ellagic acid. Mol Cell Biochem 365:119\u2013127","journal-title":"Mol Cell Biochem"},{"key":"972_CR65","doi-asserted-by":"crossref","first-page":"e17874","DOI":"10.1371\/journal.pone.0017874","volume":"6","author":"CA Boswell","year":"2011","unstructured":"Boswell CA, Ferl GZ, Mundo EE et al (2011) Effects of anti-VEGF on predicted antibody biodistribution: roles of vascular volume, interstitial volume, and blood flow. PLoS One 6:e17874","journal-title":"PLoS One"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-016-0972-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-016-0972-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-016-0972-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T22:54:16Z","timestamp":1589669656000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-016-0972-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,8]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["972"],"URL":"https:\/\/doi.org\/10.1007\/s11307-016-0972-7","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,8]]}}}